Evidence map›Paper›PMID 39065557›Full record

ArticlePharmaceutics2024

Antimicrobial Peptide Screening for Designing Custom Bactericidal Hydrogels.

Matthias Recktenwald, Muskanjot Kaur, Mohammed M Benmassaoud, Aryanna Copling, Tulika Khanna, Michael Curry, Dennise Cortes, Gilbert Fleischer, Valerie J Carabetta, Sebastián L Vega

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Nanosystems for delivery of indolicidin peptide.Frontiers in medical technology · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matthias RecktenwaldDepartment of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, USA.ORCID 0000-0002-1548-9019
Muskanjot KaurDepartment of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.
Mohammed M BenmassaoudDepartment of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, USA.
Aryanna CoplingDepartment of Translational Biomedical Sciences, Rowan University, Glassboro, NJ 08028, USA.
Tulika KhannaDepartment of Biological Sciences, Rowan University, Glassboro, NJ 08028, USA.ORCID 0009-0001-0459-0410
Michael CurryDepartment of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.
Dennise CortesDepartment of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.
Gilbert FleischerDepartment of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.
Valerie J CarabettaDepartment of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.ORCID 0000-0002-2211-0556
Sebastián L VegaDepartment of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, USA.ORCID 0000-0002-7669-1552

Funding

U-Rise at Rowan UniversityT34GM136492 · NIGMS · ROWAN UNIVERSITY · PI KECK, THOMAS MCGOWAN, NUCCI, NATHANIEL V · 2021 to 2025
$2.0M
Investigation of the physiological significance of protein acetylation in Bacillus subtilisR35GM138303 · NIGMS · ROWAN UNIVERSITY · PI CARABETTA, VALERIE JEAN · 2020 to 2024
$1.9M
NIGMS NIH HHS R35 GM138303NIGMS NIH HHS T34 GM136492NIH HHS 1R35GM136492-03A3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMP screeningantimicrobial peptideshydrogelsmedical device infectionsthiol-norbornene

Identifiers

PMID39065557
PMCPMC11279943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.